Consensus statement on ehrlichial disease of small animals from the infectious disease study group of the ACVIM. American College of Veterinary Internal Medicine.
Within the past several decades, the number of Ehrlichia spp. recognized to infect cats, dogs, and human beings has expanded substantially. The recent application of advanced techniques in molecular biology has changed how ehrlichiosis is diagnosed and has provided new tools for the assessment of treatment. As these techniques are applied, the numerous questions that relate to the management of dogs and cats with ehrlichiosis ultimately will be answered. We hope this consensus statement will assist veterinarians in the management of their patients.
Neer
T Mark
TM
Louisiana State University, Baton Rouge, USA.
Breitschwerdt
Edward B
EB
Greene
Russell T
RT
Lappin
Michael R
MR
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002371:Cat Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D002415:Cats; D003937:Diagnosis, Differential; D004283:Dog Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D004285:Dogs; D004536:Ehrlichia / Q000302:isolation & purification / Q000472:pathogenicity*; D016873:Ehrlichiosis / Q000175:diagnosis / Q000188:drug therapy / Q000662:veterinary*; D005843:Geography; D011379:Prognosis; D012698:Serologic Tests; D013987:Ticks
D000900:Anti-Bacterial Agents